Vera Therapeutics Inc
NASDAQ:VERA
Income Statement
Earnings Waterfall
Vera Therapeutics Inc
Income Statement
Vera Therapeutics Inc
| Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
3
|
3
|
4
|
5
|
6
|
7
|
8
|
8
|
7
|
7
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | |||||||||||||||||||||
| Operating Expenses |
(48)
|
(51)
|
(54)
|
(59)
|
(34)
|
(44)
|
(56)
|
(74)
|
(91)
|
(105)
|
(112)
|
(109)
|
(102)
|
(102)
|
(117)
|
(145)
|
(167)
|
(193)
|
(236)
|
(270)
|
|
| Selling, General & Administrative |
(4)
|
(5)
|
(6)
|
(9)
|
(12)
|
(15)
|
(17)
|
(19)
|
(22)
|
(24)
|
(24)
|
(24)
|
(24)
|
(26)
|
(28)
|
(32)
|
(41)
|
(49)
|
(63)
|
(81)
|
|
| Research & Development |
(44)
|
(47)
|
(48)
|
(50)
|
(22)
|
(32)
|
(39)
|
(55)
|
(69)
|
(82)
|
(88)
|
(84)
|
(78)
|
(76)
|
(89)
|
(114)
|
(126)
|
(144)
|
(173)
|
(189)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(48)
N/A
|
(51)
-7%
|
(54)
-5%
|
(59)
-9%
|
(34)
+41%
|
(44)
-28%
|
(56)
-27%
|
(74)
-32%
|
(91)
-23%
|
(105)
-16%
|
(112)
-7%
|
(109)
+3%
|
(102)
+6%
|
(102)
+0%
|
(117)
-15%
|
(145)
-24%
|
(167)
-15%
|
(193)
-16%
|
(236)
-22%
|
(270)
-14%
|
|
| Pre-Tax Income | |||||||||||||||||||||
| Interest Income Expense |
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
0
|
0
|
1
|
2
|
3
|
4
|
4
|
6
|
8
|
9
|
13
|
16
|
17
|
18
|
|
| Non-Reccuring Items |
(4)
|
(3)
|
(0)
|
1
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
0
|
1
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
1
|
0
|
|
| Pre-Tax Income |
(53)
N/A
|
(56)
-4%
|
(55)
+0%
|
(59)
-6%
|
(33)
+44%
|
(45)
-38%
|
(56)
-25%
|
(73)
-30%
|
(89)
-21%
|
(102)
-15%
|
(107)
-5%
|
(103)
+4%
|
(96)
+7%
|
(94)
+2%
|
(108)
-14%
|
(134)
-25%
|
(152)
-13%
|
(175)
-15%
|
(218)
-24%
|
(252)
-15%
|
|
| Net Income | |||||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(53)
|
(56)
|
(55)
|
(59)
|
(33)
|
(45)
|
(56)
|
(73)
|
(89)
|
(102)
|
(107)
|
(103)
|
(96)
|
(94)
|
(108)
|
(134)
|
(152)
|
(175)
|
(218)
|
(252)
|
|
| Net Income (Common) |
(53)
N/A
|
(56)
-4%
|
(55)
+0%
|
(59)
-6%
|
(33)
+44%
|
(45)
-38%
|
(56)
-25%
|
(73)
-30%
|
(89)
-21%
|
(102)
-15%
|
(107)
-5%
|
(103)
+4%
|
(96)
+7%
|
(94)
+2%
|
(108)
-14%
|
(134)
-25%
|
(152)
-13%
|
(175)
-15%
|
(218)
-24%
|
(252)
-15%
|
|
| EPS (Diluted) |
-2.61
N/A
|
-2.72
-4%
|
-2.6
+4%
|
-2.75
-6%
|
-1.53
+44%
|
-1.85
-21%
|
-2.08
-12%
|
-2.69
-29%
|
-3.35
-25%
|
-2.7
+19%
|
-2.42
+10%
|
-2.31
+5%
|
-2.25
+3%
|
-1.84
+18%
|
-1.97
-7%
|
-2.44
-24%
|
-2.75
-13%
|
-2.75
N/A
|
-3.42
-24%
|
-3.94
-15%
|
|